Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
149.00    0.00 (0.00%)
Bid:
142.50
Ask:
148.50
Spread: 6.00 (4.211%)
Market Cap: £285.60m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Final Closing

23 Mar 2017 08:14

RNS Number : 2981A
Franchise Brands PLC
23 March 2017
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

23 March 2017

Franchise Brands plc

("Franchise Brands", "the Group", or "the Company")

 

Results of proposed placing to raise £20 million

 

Further to the announcement made earlier today, the Board of Franchise Brands is pleased to announce the completion of a placing of 29,850,747 new ordinary shares of 0.5p each in the Company (the "Placing Shares") at a price of 67 pence per Placing Share (the "Placing Price") to raise a total of £20,000,000 (before expenses) (the "Placing").

 

The proceeds of the Placing will be applied towards paying part of the consideration for the acquisition of Metro Rod Limited, as announced earlier today (the "Acquisition").

 

The Placing is conditional, inter alia, on the approval of shareholders at a general meeting of the Company to be held on 10 April 2017 (the "General Meeting") of resolutions to provide authority to the Directors to issue and allot the Placing Shares and to approve the Acquisition for the purposes of rule 14 of the AIM Rules for Companies. The Placing is also conditional on admission of the Placing Shares (and the re-admission of the Existing Ordinary Shares) to trading on AIM ("Admission"). Application will be made for the Placing Shares to be admitted (and the Existing Ordinary Shares to be re-admitted) to trading on AIM and it is expected that Admission will take place on 11 April 2017.

 

The Placing Shares will represent, in aggregate, approximately 38.4 per cent. of the Company's issued ordinary share capital as enlarged by the issue of the Placing Shares.

 

The Placing Shares will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive dividends and other distributions declared, made or paid in respect of the Ordinary Shares. For the avoidance of doubt, the Placing Shares will not be eligible to receive the dividend announced in the Group's annual report and accounts for the year to 31 December 2016.

 

Further details regarding the background to the Acquisition and the Placing can be found in the Company's announcement made earlier today. .

 

Directors' participation

 

All of the Directors are participating in the Placing on identical terms to the Placees. The Directors have agreed to subscribe, in aggregate, for 16,671,459 Placing Shares at the Placing Price as follows:

 

 

Current Holding

 

At Admission

Director

Number of Ordinary Shares held

Percentage of Ordinary Shares in issue

Number of Placing Shares

Number of Ordinary Shares held

Percentage of Ordinary Shares in issue

Stephen Hemsley

13,000,431

27.15

7,462,686

20,463,117

26.33

Nigel Wray

14,080,434

29.41

7,462,686

21,543,120

27.71

David Poutney

606,060

1.27

1,417,910

2,023,970

2.60

Julia Choudhury

1,010,229

2.11

194,029

1,204,258

1.55

Tim Harris

999,762

2.09

59,222

1,059,284

1.36

Robin Auld

908,882

1.90

37,313

946,195

1.22

Rob Bellhouse

45,455

0.09

37,313

82,768

0.11

Total

30,651,253

64.02

16,671,459

47,322,712

60.88

 

The Directors are treated as related parties of the Company under the AIM Rules. The Directors' participation in the Placing is therefore treated as a related party transaction pursuant to rule 13 of the AIM Rules. Accordingly, the Company's nominated adviser, Allenby Capital, considers that the terms of the Directors' participation in the Placing are fair and reasonable insofar as Shareholders are concerned.

 

Total Voting Rights

The Placing is conditional, among other things, upon Admission becoming effective. Following Admission, the Company's issued ordinary share capital will consist of 77,732,033 Ordinary Shares, with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 77,732,033. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Unless otherwise defined, the defined terms used in this Announcement shall have the same meaning (unless the context otherwise requires) as ascribed to them in the "Definitions" and "Technical Glossary" section in the Admission Document published by the Company earlier today.

 

**ENDS**

Enquiries:

Franchise Brands plc + 44 (0) 800 012 6462

Stephen Hemsley, Executive Chairman

Julia Choudhury, Corporate Development Director

 

MHP Communications +44 (0) 20 3128 8100(Financial PR) franchisebrands@mhpc.com

Katie Hunt / Hannah Winter

 

Allenby Capital Limited +44 (0) 20 3328 5656(Nominated Adviser and Joint Broker)

Jeremy Porter/ James Thomas / Liz Kirchner

 

Dowgate Capital Stockbrokers +44 (0)1293 517744

(Joint Broker)

James Serjeant / Neil Badger

 

IMPORTANT NOTICE

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY, IS NOT INTENDED TO AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, UNDERWRITE, SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE, SELL, ACQUIRE, DISPOSE OF THE PLACING SHARES OR ANY OTHER SECURITY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN ANY JURISDICTION IN WHICH, OR TO ANY PERSONS TO WHOM, SUCH OFFERING, SOLICITATION OR SALE WOULD BE UNLAWFUL.

Allenby Capital Limited is authorised and regulated in the United Kingdom by the Financial Conduct Authority ("FCA") and is acting exclusively for the Company in connection with the Acquisition, Placing and Admission and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any other person in relation to the Acquisition, Placing, Admission and/or any other matter referred to in this Announcement.

Dowgate Capital Stockbrokers Limited is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company in connection with the Acquisition, Placing and Admission and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any other person in relation to the Acquisition, Placing, Admission and/or any other matter referred to in this Announcement.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Allenby Capital or Dowgate Capital or any of their respective affiliates or any of their respective directors, officers, employees, advisers or representatives (collectively, "Representatives") as to or in relation to the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROISEESADFWSEFD
Date   Source Headline
7th Dec 20217:00 amRNSDirectorate Change
29th Nov 20217:00 amRNSAcquisition of Azura & total voting rights
22nd Nov 20217:00 amRNSDirector/PDMR Shareholding
2nd Nov 20217:00 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSThe Global Group UK Investor Summit
22nd Jul 20217:00 amRNSInterim Results
5th Jul 20217:00 amRNSTrading Update and Notice of Interim Results
1st Jul 20217:00 amRNSShare purchase programme
16th Jun 20212:06 pmRNSSecond Price Monitoring Extn
16th Jun 20212:00 pmRNSPrice Monitoring Extension
16th Jun 20217:29 amRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSLockdown easing leads to record job numbers
20th Apr 202111:34 amRNSResult of AGM
20th Apr 20217:00 amRNSAGM Statement and Trading Update
4th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSInvestor Presentation
18th Feb 20217:00 amRNSInvestor Presentation
25th Jan 20217:00 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSTrading Update and Notice of Full Year Results
31st Dec 20207:00 amRNSShare purchase programme
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
30th Oct 20205:00 pmRNSTotal Voting Rights
28th Oct 20202:01 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSQ3 Trading Update
28th Sep 20207:00 amRNSDirector shareholdings, issue of equity & TVR
22nd Sep 20207:00 amRNSDirector/PDMR Shareholding
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
16th Sep 20207:00 amRNSGrant under New Share Option Scheme, PDMR Dealings
30th Jul 20207:00 amRNSInterim Results
7th Jul 20207:00 amRNSNotice of Results
1st Jul 20207:00 amRNSShare purchase programme and EBT
30th Jun 20205:00 pmRNSTotal Voting Rights
25th Jun 20207:00 amRNSExercise of Options and Other Matters
9th Jun 20204:00 pmRNSDirectors’ shareholdings
3rd Jun 20207:00 amRNSResult of scrip dividend and change to TVR
22nd May 20204:42 pmRNSHolding(s) in Company
1st May 20205:10 pmRNSHoldings in Company and director’s holding
30th Apr 20205:00 pmRNSTotal Voting Rights
30th Apr 202010:40 amRNSHolding(s) in Company
29th Apr 20209:00 amRNSHolding(s) in Company
28th Apr 20203:05 pmRNSHolding(s) in Company
28th Apr 202011:19 amRNSResult of Annual General Meeting
28th Apr 20208:30 amRNSHoldings in Company and director’s holding
27th Apr 202012:00 pmRNSHolding(s) in Company
21st Apr 202012:44 pmRNSResult of Bookbuild
20th Apr 20204:38 pmRNSProposed Placing and Trading Update
7th Apr 20207:00 amRNSBoard & senior management scrip dividend election

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.